TAYLOR MORRISON HOME CORP (TMHC) Fundamental Analysis & Valuation
NYSE:TMHC • US87724P1066
Current stock price
57.7 USD
-0.04 (-0.07%)
Last:
This TMHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TMHC Profitability Analysis
1.1 Basic Checks
- TMHC had positive earnings in the past year.
- TMHC had a positive operating cash flow in the past year.
- Each year in the past 5 years TMHC has been profitable.
- Each year in the past 5 years TMHC had a positive operating cash flow.
1.2 Ratios
- TMHC has a Return On Assets of 7.95%. This is in the better half of the industry: TMHC outperforms 80.00% of its industry peers.
- Looking at the Return On Equity, with a value of 12.43%, TMHC is in the better half of the industry, outperforming 71.67% of the companies in the same industry.
- The Return On Invested Capital of TMHC (9.79%) is better than 71.67% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for TMHC is in line with the industry average of 9.09%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.95% | ||
| ROE | 12.43% | ||
| ROIC | 9.79% |
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
1.3 Margins
- With an excellent Profit Margin value of 9.63%, TMHC belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
- TMHC's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 13.87%, TMHC belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
- TMHC's Operating Margin has improved in the last couple of years.
- With a Gross Margin value of 23.38%, TMHC is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of TMHC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.87% | ||
| PM (TTM) | 9.63% | ||
| GM | 23.38% |
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
2. TMHC Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TMHC is still creating some value.
- TMHC has less shares outstanding than it did 1 year ago.
- TMHC has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, TMHC has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.63 indicates that TMHC is not in any danger for bankruptcy at the moment.
- TMHC has a Altman-Z score (3.63) which is in line with its industry peers.
- TMHC has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as TMHC would need 2.95 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 2.95, TMHC is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- A Debt/Equity ratio of 0.36 indicates that TMHC is not too dependend on debt financing.
- The Debt to Equity ratio of TMHC (0.36) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.95 | ||
| Altman-Z | 3.63 |
ROIC/WACC1.07
WACC9.16%
2.3 Liquidity
- A Current Ratio of 6.81 indicates that TMHC has no problem at all paying its short term obligations.
- TMHC has a better Current ratio (6.81) than 78.33% of its industry peers.
- A Quick Ratio of 1.03 indicates that TMHC should not have too much problems paying its short term obligations.
- TMHC has a Quick ratio (1.03) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.81 | ||
| Quick Ratio | 1.03 |
3. TMHC Growth Analysis
3.1 Past
- TMHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.51%.
- The Earnings Per Share has been growing by 23.33% on average over the past years. This is a very strong growth
- The Revenue has decreased by -0.57% in the past year.
- Measured over the past years, TMHC shows a small growth in Revenue. The Revenue has been growing by 5.79% on average per year.
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%
3.2 Future
- TMHC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.38% yearly.
- TMHC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.12% yearly.
EPS Next Y-31.59%
EPS Next 2Y-7.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.63%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. TMHC Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 7.44, the valuation of TMHC can be described as very cheap.
- Based on the Price/Earnings ratio, TMHC is valued cheaper than 88.33% of the companies in the same industry.
- TMHC is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 10.87 indicates a reasonable valuation of TMHC.
- Based on the Price/Forward Earnings ratio, TMHC is valued a bit cheaper than 71.67% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of TMHC to the average of the S&P500 Index (38.20), we can say TMHC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.44 | ||
| Fwd PE | 10.87 |
4.2 Price Multiples
- 78.33% of the companies in the same industry are more expensive than TMHC, based on the Enterprise Value to EBITDA ratio.
- TMHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TMHC is cheaper than 88.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.15 | ||
| EV/EBITDA | 6 |
4.3 Compensation for Growth
- The decent profitability rating of TMHC may justify a higher PE ratio.
- A cheap valuation may be justified as TMHC's earnings are expected to decrease with -7.38% in the coming years.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-7.38%
EPS Next 3YN/A
5. TMHC Dividend Analysis
5.1 Amount
- No dividends for TMHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TMHC Fundamentals: All Metrics, Ratios and Statistics
NYSE:TMHC (4/16/2026, 1:28:03 PM)
57.7
-0.04 (-0.07%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-11 2026-02-11/bmo
Earnings (Next)04-22 2026-04-22
Inst Owners101.83%
Inst Owner Change0.23%
Ins Owners0.59%
Ins Owner Change13.67%
Market Cap5.56B
Revenue(TTM)8.12B
Net Income(TTM)782.50M
Analysts78.82
Price Target78.36 (35.81%)
Short Float %5.46%
Short Ratio4.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.42%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)1.13%
Min EPS beat(4)-2.85%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)2.57%
EPS beat(12)7
Avg EPS beat(12)4.91%
EPS beat(16)10
Avg EPS beat(16)6.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)1.08%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)5
Avg Revenue beat(8)0.84%
Revenue beat(12)9
Avg Revenue beat(12)3%
Revenue beat(16)12
Avg Revenue beat(16)2.4%
PT rev (1m)1.35%
PT rev (3m)3.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29.02%
EPS NY rev (1m)0.47%
EPS NY rev (3m)-22.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.79%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-6.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.44 | ||
| Fwd PE | 10.87 | ||
| P/S | 0.68 | ||
| P/FCF | 7.15 | ||
| P/OCF | 6.8 | ||
| P/B | 0.88 | ||
| P/tB | 0.99 | ||
| EV/EBITDA | 6 |
EPS(TTM)7.76
EY13.45%
EPS(NY)5.31
Fwd EY9.2%
FCF(TTM)8.07
FCFY13.98%
OCF(TTM)8.48
OCFY14.71%
SpS84.31
BVpS65.33
TBVpS58.45
PEG (NY)N/A
PEG (5Y)0.32
Graham Number106.802 (85.1%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.95% | ||
| ROE | 12.43% | ||
| ROCE | 12.83% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.84% | ||
| ROICexgc | 11.83% | ||
| OM | 13.87% | ||
| PM (TTM) | 9.63% | ||
| GM | 23.38% | ||
| FCFM | 9.57% |
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
ROICexc(3y)11.72%
ROICexc(5y)12.31%
ROICexgc(3y)13.58%
ROICexgc(5y)14.24%
ROCE(3y)14.02%
ROCE(5y)14.61%
ROICexgc growth 3Y-12.31%
ROICexgc growth 5Y15.36%
ROICexc growth 3Y-12.76%
ROICexc growth 5Y14.64%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
F-Score5
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.95 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 100.47% | ||
| Cap/Sales | 0.5% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.07% | ||
| Profit Quality | 99.29% | ||
| Current Ratio | 6.81 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 3.63 |
F-Score5
WACC9.16%
ROIC/WACC1.07
Cap/Depr(3y)96.24%
Cap/Depr(5y)86.45%
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.41%
Profit Quality(3y)73.15%
Profit Quality(5y)75.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
EPS Next Y-31.59%
EPS Next 2Y-7.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%
Revenue Next Year-15.63%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.24%
EBIT growth 3Y-6.83%
EBIT growth 5Y20.52%
EBIT Next Year-28.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y347.18%
FCF growth 3Y-10.32%
FCF growth 5Y-6.47%
OCF growth 1Y289.07%
OCF growth 3Y-9.64%
OCF growth 5Y-6.16%
TAYLOR MORRISON HOME CORP / TMHC Fundamental Analysis FAQ
What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?
ChartMill assigns a fundamental rating of 5 / 10 to TMHC.
What is the valuation status for TMHC stock?
ChartMill assigns a valuation rating of 7 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.
Can you provide the profitability details for TAYLOR MORRISON HOME CORP?
TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 7 / 10.
Can you provide the financial health for TMHC stock?
The financial health rating of TAYLOR MORRISON HOME CORP (TMHC) is 6 / 10.